Apogee Therapeutics (APGE) Stock: Buy, Sell, or Hold?
APGE - Apogee Therapeutics, Inc. Common Stock
$135.07
-0.01 (-0.01%)
▼
5d:
+0.09%
30d:
+0.66%
90d:
+60.43%
HOLD
MODERATE Confidence
Analysis Updated: Sep 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When APGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: APGE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: APGE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: APGE is currently trading at $135.07, which is considered extended relative to its 30-day fair value range of $134.42 to $134.96.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is currently testing key support at $134.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is currently testing key support at $134.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$134.42 -
$134.96
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
APGE is technically overbought (RSI 77). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($134.85)
- NEUTRAL: Bottoming setup forming (44/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$134.42 -
$134.96
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.83
(0.6%)
Support & Resistance Levels
Support Level
$134.68
Resistance Level
$135.09
Current Trend
Strong Uptrend
Technical data as of
Sep 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.81
Wall Street Target
$134.85
(-0.2%)
Share & Embed Analysis
Last updated: September 11, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
Data refreshes hourly during market hours. Next update: 8:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Thomas Henderson
SELL
20000 shares
2026-04-08
Carl Dambkowski
SELL
5500 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 50 HOLD |
|
JSPR
Jasper Therapeutics Inc |
STRONG BUY
11 analysts |
$7 | 62 BUY |
|
RLAY
Relay Therapeutics Inc |
STRONG BUY
13 analysts |
$27 | 64 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 44 HOLD |
Advanced APGE Option Strategies
Professional options setups generated by AI based on today's APGE price and gamma walls.
